Back
All American Gold Vs. Monopar Therapeutics Industry Stock Comparison
Sell
38
AAGC
All American Gold
Last Price:
$0.0000
Seasonality Move:
89.18%
Sell
46
MNPR
Monopar Therapeutics
Last Price:
$37.99
Seasonality Move:
-13.48%
Sell
38
All American Gold (AAGC)
is a Sell
Is All American Gold a Buy, Sell or Hold?
-
The current All American Gold [AAGC] share price is $0.0009. The Score for AAGC is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
AAGC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Monopar Therapeutics (MNPR)
is a Sell
Is Monopar Therapeutics a Buy, Sell or Hold?
-
The current Monopar Therapeutics [MNPR] share price is $37.60. The Score for MNPR is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AAGC Stock Price Chart
What is All American Gold's stock price today?
-
The All American Gold share price today is $0.0009Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AAGC is experiencing slight selling pressure.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $37.60The current trend is moderately bullish and MNPR is experiencing slight selling pressure.
AAGC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0 | Sell |
Relative Strength Index (14 RSI): | 45.41 | Sell |
Chaikin Money Flow: | 1323433 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.001 - 0.001) | Sell |
Bollinger Bands (100): | (0.0011 - 0.0011) | Sell |
MNPR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.33 | Buy |
Relative Strength Index (14 RSI): | 53.16 | Buy |
Chaikin Money Flow: | -4864 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.9 - 41.16) | Buy |
Bollinger Bands (100): | (18.89 - 38.95) | Buy |
AAGC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0 | Sell |
20-day SMA: | 0 | Sell |
50-day SMA: | 0 | Sell |
200-day SMA: | 0 | Sell |
8-day EMA: | 0 | Sell |
20-day EMA: | 0 | Sell |
50-day EMA: | 0 | Buy |
200-day EMA: | 0 | Buy |
MNPR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 36.16 | Buy |
20-day SMA: | 33.55 | Buy |
50-day SMA: | 36.72 | Buy |
200-day SMA: | 16.35 | Buy |
8-day EMA: | 37.12 | Buy |
20-day EMA: | 35.96 | Buy |
50-day EMA: | 34.41 | Buy |
200-day EMA: | 21.02 | Buy |
All American Gold Earnings Growth & AAGC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $2.24 per share.
All American Gold Technical Analysis
Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Monopar Therapeutics Technical Analysis
Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |